FindTrial
Sign In

Effect of unani medicine in the treatment of Polycystic Ovarian disease. An open Observational study

Effect of Saleekha and Majeeth in Polycystic Ovarian disease. An open Observational study - PCOD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031070
Enrollment
30
Registered
2021-02-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

Intervention1: Majeeth (Rubia cordifolia) -14gm and Saleekha(Tajkalmi-Cinnamomum cassia)-7gm. : Safoof and Decoction as per standard preparation Safoof of Saleekha 3.5gm BD with Joshanda of Majeeth 7g

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Oligomenorrhoea or amenorrhoea. USG finding of PCOD. Obesity

Exclusion criteria

Exclusion criteria: Endometrial tuberculosis. Malignancies. Systemic and endocrine diseases. Pregnancy, lactation and on contraceptive

Design outcomes

Primary

MeasureTime frame
changes in subjective parameter Timepoint: Nature of cycle, duration of cycle, duration of flow, amount of flow. Clinical sign of hyperandrogenism. obesity—

Secondary

MeasureTime frame
PBAC score SF-12 survey to assess QOL BMI and Waist circumference Ovarian volume Timepoint: After 3 cycles—

Countries

India

Contacts

Public ContactWajeeha Begum

National Institute of Unani Medicine

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026